Steroid Resistance During COPD Exacerbations With Respiratory Failure
Targeting Steroid Resistance During Acute Exacerbations of Chronic Obstructive Pulmonary Disease With Respiratory Failure - The AECOPD Resistance Study
Sponsor: National Jewish Health
Listed as NCT03680495, this observational or N/A phase trial focuses on COPD and COPD Exacerbation and remains ongoing. Sponsored by National Jewish Health, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Feb 2020 [monthly]
Recruiting
-
Oct 2018 — Feb 2019 [monthly]
Recruiting
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Jewish Health
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .